Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipients

Transplant Proc. 2003 Feb;35(1):215-6. doi: 10.1016/s0041-1345(02)03839-3.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Area Under Curve
  • Costs and Cost Analysis
  • Cyclosporine / economics*
  • Cyclosporine / pharmacokinetics
  • Cyclosporine / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / economics*
  • Immunosuppressive Agents / therapeutic use*
  • Ketoconazole / therapeutic use*
  • Kidney Transplantation / economics
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Male
  • Survival Rate
  • Time Factors
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Ketoconazole